MyFinsight
Home
Compare
Blog
About
Maturities of investments
$60,000K
Proceeds from issuance of
common stock under espp
$679K
Proceeds from stock
option exercises
$149K
Net cash (used in)
provided by investing...
$11,864K
Net cash provided by
financing activities
$828K
Canceled cashflow
$48,136K
Net (decrease)
increase in cash, cash...
-$18,913K
Canceled cashflow
$12,692K
Stock-based compensation
expense
$7,091K
Accounts payable and
accrued other...
$2,220K
Amortization of premium
(accretion of discount) on...
-$291K
Depreciation
$264K
Prepaid expenses and
other assets
-$21K
Purchases of investments
$47,780K
Acquisitions of property and
equipment
$356K
Net cash used in
operating activities
-$31,605K
Canceled cashflow
$9,887K
Net loss
-$41,492K
Back
Back
Cash Flow
Oric Pharmaceuticals, Inc. (ORIC)
Oric Pharmaceuticals, Inc. (ORIC)
source: myfinsight.com